AACI Commentary

About Our Editorial Series

Exploring Topics of Interest to AACI Cancer Centers

To promote the work of its member centers, AACI publishes Commentary, an editorial series focusing on major issues of common interest to North American cancer centers. 

Each AACI Commentary is written by a cancer center leader or subject matter expert and distributed by email to the more than 2,500 readers of the AACI Update newsletter. 

The publication is designed to cover a specific topic in 750-1,000 words. Recommendations for topics and authors are encouraged. 


Please submit suggestions to: 

Chris Zurawsky
Director of Communications and Public Affairs
412-802-6775

Emily Stimmel
Communications and External Relations Coordinator
412-647-0504


May 2020

COVID-19 
How AACI’s Corporate Partners Are Helping Cancer Centers and Their Patients Weather the Pandemic

As AACI continues to closely monitor the coronavirus pandemic, we are pleased to share this overview of ways that our Corporate Roundtable members are directly supporting cancer centers and their patients during these unprecedented and challenging times.

The AACI Corporate Roundtable provides a forum for AACI cancer centers to address topics of mutual interest with their pharmaceutical industry colleagues. This interaction has the potential to advance the progress of research and ultimately benefit patients with cancer and their families.

COVID-19 assistance from our corporate partners covers a wide range of activities, from maintaining the integrity of clinical trials and ensuring the flow of protective equipment and other supplies to cancer centers, to accelerating vaccine development and providing medicine to patients facing financial hardship.

AACI thanks its Corporate Roundtable members for sharing information about their cancer-related COVID-19 work and for their ongoing support and commitment: AbbVie, Amgen, Astellas, Bristol Myers Squibb, Genentech, Janssen Pharmaceuticals, Kite, Lilly, Merck, Pfizer, and Takeda Oncology

Read the May 2020 Commentary.

Zip Code vs. Genetic Code: Breaking Down Cancer Disparities in Philadelphia
By Karen E. Knudsen, PhD
October 2017

Satisfaction with Oncology Quality and Clinical Operations: A survey from the AACI Physician Clinical Leadership Initiative (PCLI)
By Morgan Dodson, Michael Neuss, Laura Hutchins, Richard Lauer, John Sweetenham, Nathan Levitan, Martha Mims, Mohammed Milhem, Craig Bunnell, Dan Mulkerin, Randall F. Holcombe
Fall 2017

SF CAN: A City Working Together to Fight Cancer 
By Alan Ashworth, PhD, FRS
Summer 2017

Integrating Clinical Research into Clinical Care
By Martha Mims, MD, PHD & Sarah McNees, PHD
Spring 2017